Since the founding of CURE by Dr. Morton I. Grosssman in 1973, a strong tradition of expertise has existed for exploring the physiological mechanisms involved in the regulation of GI function under normal and pathological conditions, as recently reviewed by the Animal Models Core Co-Director (1). In the past two decades, tremendous increases in knowledge derived from cell and molecular biological approaches have driven interest to evaluate in vitro findings within the context of integrative physiological models. Conversely, observations derived from the role of specific endogenous hormones or transmitters in the regulation of normal or abnormal GI functions in in vivo models have provided the impetus for focused mechanistic evaluation at the cellular level using molecular biological methods. Indeed, a common theme in many of the research programs of the Center investigators is the elucidation of the pathophysiological role and molecular mechanism of action of gastrointestinal peptide hormones, neuropeptides, paracrine regulators and classical neurotransmitters. Thus, in vivo studies are important for the implementation of many research programs of CURE: DDRCC members to: 1. Assess the biological significance of mechanisms elucidated in vitro; 2. Dissect the neural, hormonal and paracrine mechanisms involved in integrated physiological regulation of GI function; 3. Test biological activity of new reagents (i.e., antibodies, selective receptor agonists or antagonists or novel peptides); 4. Establish relevant models of GI diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK041301-21
Application #
7767523
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (M1))
Project Start
2009-12-01
Project End
2014-11-30
Budget Start
2010-02-20
Budget End
2010-11-30
Support Year
21
Fiscal Year
2010
Total Cost
$119,855
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Jensen, Dennis M; Eklund, Stefan; Persson, Tore et al. (2017) Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial. Am J Gastroenterol 112:441-446
Giancola, F; Torresan, F; Repossi, R et al. (2017) Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation. Neurogastroenterol Motil 29:
Yu, Juehua; Liu, Shi-He; Sanchez, Robbi et al. (2017) Pancreatic cancer actionable genes in precision medicine and personalized surgery. Surgeon 15:24-29
Gupta, A; Mayer, E A; Hamadani, K et al. (2017) Sex differences in the influence of body mass index on anatomical architecture of brain networks. Int J Obes (Lond) 41:1185-1195
Chang, Jen-Kuan; Ni, Yang; Han, Liang et al. (2017) Protein kinase D1 (PKD1) phosphorylation on Ser203 by type I p21-activated kinase (PAK) regulates PKD1 localization. J Biol Chem 292:9523-9539
Jackson, Samuel B; Villano, Nicholas P; Benhammou, Jihane N et al. (2017) Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature. Dig Dis Sci 62:2623-2630
Chang, Hui-Hua; Moro, Aune; Takakura, Kazuki et al. (2017) Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. PLoS One 12:e0184455
Yuan, Pu-Qing; Taché, Yvette (2017) Abdominal surgery induced gastric ileus and activation of M1-like macrophages in the gastric myenteric plexus: prevention by central vagal activation in rats. Am J Physiol Gastrointest Liver Physiol 313:G320-G329
Pérez de Sevilla Müller, Luis; Solomon, Alexander; Sheets, Kristopher et al. (2017) Multiple cell types form the VIP amacrine cell population. J Comp Neurol :
Kaji, Izumi; Akiba, Yasutada; Kato, Ikuo et al. (2017) Xenin Augments Duodenal Anion Secretion via Activation of Afferent Neural Pathways. J Pharmacol Exp Ther 361:151-161

Showing the most recent 10 out of 976 publications